Extract Technology – Huddersfield, UK announce their continued involvement in ACHEMA for 2022 showcasing cell therapy solutions, among other aseptic and containment technologies within their portfolio at Hall 3.1 Booth F4. Extract Technology has proudly served this specialty ATMP and cell and gene therapy space for over a decade.
This year, along with strategic product lines, Extract Technology and the Dec Group (Dietrich Engineering Consultants) announced significant expansion of two global manufacturing facilities. Extract Technology’s UK ISO 9001 manufacturing facility located in Huddersfield, UK, and their ASME NQA-1 facility in Wisconsin, United States. The UK site expansion includes the acquisition of an additional building within the current industrial complex. The expansion serves to support the growing needs of Extract Technology’s global customer base and to add further efficiency to UK manufacturing operations.
Since acquisition by the Dec Group in 2021, this is the 2nd major investment announcement in the Extract Technology business with respect to infrastructure.
Initiatives driving the expansions include increases in capacity and optimizing manufacturing layout to create a more customer-focused environment. The investment drives further innovation of Dec Group technologies including innovative modular Cell and Gene Therapy Processing Isolator technology.
The Extract US expansion will come online in late 2022 and will house a new world-class manufacturing facility. The Wisconsin facility will include one of the largest NQA-1 operations in North America, servicing the needs for Nuclear Grade Isolation (including Radiopharma applications), and support our manufacturing of GMP Modular Cleanroom (MCR) products by Extract Technology.
Extract Technology invites all visitors to join them at Hall 3.1 Booth F4 and speak with subject matter experts on a range of application areas.
About Extract Technology
Extract Technology has over 70 years of engineering heritage in aseptic and containment systems for pharmaceutical, biopharmaceutical, nuclear containment, and radiopharmaceutical applications.
Manufacturing sites are located in Wisconsin, USA, and Huddersfield, UK.
Extract Technology specializes in isolators and downflow booths with process integrations including for use in pharmaceutical manufacturing, cell and gene therapy processing, sterility testing, liquid and powder filling, and research and development. Equipment solutions from Extract Technology also include GMP modular cleanrooms, cell therapy processing isolators, LAF Carts, RABS, and lab benches. The Walker Barrier Systems brand serves nuclear containment, government, and defense clientele. Nuclear containment gloveboxes and hot cells are manufactured under a strict NQA-1 quality program.
About Dec Group
Dec Group (Dietrich Engineering Consultants) is a leading global provider of contained powder handling systems and is recognized as a world-leading expert in process containment technologies. It has been supplying the pharmaceutical, chemical, food, and cosmetic industries for more than 30 years.
Headquartered near Lausanne, Switzerland, Dec Group has a global presence with subsidiaries and agents in more than 50 countries including subsidiaries in the UK, Ireland, Germany, Poland, the Netherlands, India, China, and the USA.
In excess of 600 companies worldwide have successfully integrated more than 9,000 Dec systems into their production sites. These include a wide range of patented products that enhance safety, hygiene, containment, reliability, and productivity in powder handling.
Dec offers innovative approaches across the range of powder handling and process containment applications, including transfer, micronizing, filling/emptying, sampling, blending, dosing, aseptic solutions, milling, isolators and advanced cleaning (CIP/SIP) features.
Contact United Kingdom:
Extract Technology, Huddersfield, UK
+44 1484 432727
Contact United States:
Andrea Bunce, US Business Development